Publikationer

Ett urval av våra publikationer

1. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Janson ET, Sorbye H, Welin S, Federspiel B, Grønbæk H, Hellman P, Ladekarl M, Langer SW, Mortensen J, Schalin-Jäntti C, Sundin A, Sundlöv A, Thiis-Evensen E, Knigge U. Acta Oncol. 2014 Oct;53(10):1284-97. doi: 10.3109/0284186X.2014.941999.

2. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Forsberg LA, Rasi C, Malmqvist N, Davies H, Pasupulati S, Pakalapati G, Sandgren J, Diaz de Ståhl T, Zaghlool A, Giedraitis V, Lannfelt L, Score J, Cross NC, Absher D, Janson ET, Lindgren CM, Morris AP, Ingelsson E, Lind L, Dumanski JP. Nat Genet. 2014 Jun;46(6):624-8. doi: 10.1038/ng.2966.

3. TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors. Edfeldt K, Ahmad T, Åkerström G, Janson ET, Hellman P, Stålberg P, Björklund P, Westin G. Endocr Relat Cancer. 2014 Feb 27;21(2):275-84. doi: 10.1530/ERC-13-0419.

4. Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors. Welin S, Stridsberg M, Cunningham J, Granberg D, Skogseid B, Oberg K, Eriksson B, Janson ET. Neuroendocrinology. 2009;89(3):302-7. doi: 10.1159/000179900.

5. Ghrelin and obestatin in human neuroendocrine tumors: expression and effect on obestatin levels after food intake. Grönberg M, Tsolakis AV, Holmbäck U, Stridsberg M, Grimelius L, Janson ET. Neuroendocrinology. 2013;97(4):291-9

6. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U. Ann Oncol. 2013 Jan;24(1):152-60

7. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer. Grönberg M, Fjällskog ML, Jirström K, Janson ET. Acta Oncol. 2012 Mar;51(3):386-93

8. Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors. Cunningham J, Diaz de Ståhl T, Sjöblom T, Westin G, Dumanski J, Janson ET. Genes Chromosomes and Cancer 2011;50:82-9

9. Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Welin S, Sorbye H, Sebjornsen S, Knappskog S, Busch C, Oberg K. Cancer. 2011 Oct 15;117(20):4617-22

10. Serotonin-producing Carcinoid Tumours: The presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.Cunningham J, Grimelius L. Sundin A, Agarwal S, Janson ET. Acta Oncologica 2007;46:747-756..

11. Malignant gastric ghrelinoma with hyperghrelinemia. Tsolakis AV, Portela Gomes GM, Stridsberg M, Grimelius L, Sundin A, Eriksson B, Öberg K, Janson ET. J Clin Endocrinol Metabol 2004; 89:3739-3744.

12. Carcinoid tumors - analysis of prognostic factors and survival 301 patients from a referral center. Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, Öberg K. Annals of Oncology 1997; 8: 685-690.

Publikationer från Onkologisk endokrinologi

Här visas de 50 senaste publikationerna från forskargruppen Onkologisk endokrinologi.

Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation.

Kjaer, Josefine; Smith, Sara; Hellman, Per; Stålberg, Peter et al.

Ingår i World Journal of Surgery, s. 340-347, 2023.

DOI för Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation. Ladda ner fulltext (pdf) av Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation.

Open access
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

Papantoniou, Dimitrios; Grönberg, Malin; Thiis-Evensen, Espen; Sorbye, Halfdan et al.

Ingår i Endocrine-Related Cancer, 2023.

DOI för Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort Ladda ner fulltext (pdf) av Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

Open access
Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours

Almeamar, Hussein; Cullen, Lisa; Murphy, David J.; Crowley, Rachel K. et al.

Ingår i Journal of neuroendocrinology, 2022.

DOI för Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours
Loss of Y in leukocytes as a risk factor for critical COVID-19 in men

Bruhn-Olszewska, Bozena; Davies, Hanna; Sarkisyan, Daniil; Juhas, Ulana et al.

Ingår i Genome Medicine, 2022.

DOI för Loss of Y in leukocytes as a risk factor for critical COVID-19 in men Ladda ner fulltext (pdf) av Loss of Y in leukocytes as a risk factor for critical COVID-19 in men

Open access
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

Kjaer, Josefin; Clancy, Thomas E.; Thornell, Anders; Andersson, Niklas et al.

Ingår i Annals of Surgery Open, 2022.

DOI för Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study Ladda ner fulltext (pdf) av Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

Open access
Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Mollazadegan, Kazhan; Skogseid, Britt; Botling, Johan; Åkerström, Tobias et al.

Ingår i Endocrine Connections, 2022.

DOI för Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors Ladda ner fulltext (pdf) av Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Open access
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)

Naeser, Ylva; Helgadottir, Hildur; Hansson, Johan; Ingvar, Christian et al.

Ingår i Cancers, 2022.

DOI för Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study) Ladda ner fulltext (pdf) av Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)

Open access
Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels

Sundblom, Jimmy; Persson Skare, Tor; Holm, Olivia; Welin, Staffan et al.

Ingår i PLOS ONE, 2022.

DOI för Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels Ladda ner fulltext (pdf) av Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels

Open access
Systemic treatment in patients with malignant pleural mesothelioma - real life experience

Ziolkowska, Barbara; Cybulska-Stopa, Bozena; Papantoniou, Dimitrios; Suwinski, Rafal

Ingår i BMC Cancer, 2022.

DOI för Systemic treatment in patients with malignant pleural mesothelioma - real life experience Ladda ner fulltext (pdf) av Systemic treatment in patients with malignant pleural mesothelioma - real life experience

Open access
Taxane-induced pain in breast cancer patients as perceived by nurses

Borjesson, Susanne; Nordin, Karin; Fjällskog, Marie-Louise; Peterson, Magnus et al.

Ingår i Acta Oncologica, s. 412-418, 2021.

DOI för Taxane-induced pain in breast cancer patients as perceived by nurses
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome

Dillon, Joseph S.; Kulke, Matthew H.; Hörsch, Dieter; Anthony, Lowell B. et al.

Ingår i Journal of Gastrointestinal Cancer, s. 212-221, 2021.

DOI för Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome Ladda ner fulltext (pdf) av Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome

Open access
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Elvebakken, Hege; Perren, Aurel; Scoazec, Jean-Yves; Tang, Laura H. et al.

Ingår i Neuroendocrinology, s. 883-894, 2021.

DOI för A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Open access
177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Fröss-Baron, Katarzyna; Garske, Ulrike; Welin, Staffan; Granberg, Dan et al.

Ingår i Neuroendocrinology, s. 330-343, 2021.

DOI för 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants Ladda ner fulltext (pdf) av 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Open access
Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging

Jawlakh, Hiba; Velikyan, Irina; Welin, Staffan; Sundin, Anders

Ingår i Journal of neuroendocrinology, 2021.

DOI för Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging Ladda ner fulltext (pdf) av Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI are superior to Ga-68-DOTATOC-PET/CT for neuroendocrine tumour imaging

Open access
Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases

Kjaer, Josefin; Stålberg, Peter; Crona, Joakim; Welin, Staffan et al.

Ingår i BJS Open, 2021.

DOI för Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases Ladda ner fulltext (pdf) av Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases

Open access
A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors

Kjellman, Magnus; Knigge, Ulrich; Welin, Staffan; Thiis-Evensen, Espen et al.

Ingår i Neuroendocrinology, s. 840-849, 2021.

DOI för A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors
Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre

Lase, Ieva; Grönberg, Malin; Norlén, Olov; Stålberg, Peter et al.

Ingår i Journal of neuroendocrinology, 2021.

DOI för Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre

Open access
Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

Papantoniou, Dimitrios; Grönberg, Malin; Landerholm, Kalle; Welin, Staffan et al.

Ingår i Endocrine (Basingstoke), s. 893-904, 2021.

DOI för Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2 Ladda ner fulltext (pdf) av Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

Open access
Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

Pommergaard, Hans-Christian; Nielsen, Kirstine; Sorbye, Halfdan; Federspiel, Birgitte et al.

Ingår i Journal of neuroendocrinology, 2021.

DOI för Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Tiensuu Janson, Eva; Knigge, Ulrich; Dam, Gitte; Federspiel, Birgitte et al.

Ingår i Acta Oncologica, s. 931-941, 2021.

DOI för Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms Ladda ner fulltext (pdf) av Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Open access
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Langer, Seppo W.; Federspiel, Birgitte; Hjortland, Geir Olav et al.

Ingår i PLOS ONE, 2020.

DOI för PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3 Ladda ner fulltext (pdf) av PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Open access
Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Perren, Aurel; Lindskog, Cecilia; Welin, Staffan et al.

Ingår i Scientific Reports, 2020.

DOI för Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3 Ladda ner fulltext (pdf) av Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

Open access
High-grade progression confers poor survival in pancreatic neuroendocrine tumors

Botling, Johan; Lamarca, Angela; Bajic, Duska; Norlén, Olov et al.

Ingår i Neuroendocrinology, s. 891-898, 2020.

DOI för High-grade progression confers poor survival in pancreatic neuroendocrine tumors
Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Dam, Gitte; Gronbaek, Henning; Sorbye, Halfdan; Evensen, Espen Thiis et al.

Ingår i Neuroendocrinology, s. 217-224, 2020.

DOI för Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors
Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission

Juhlin, Carl Christofer; Falhammar, Henrik; Kjellman, Magnus; Ahlen, Jan et al.

Ingår i BMC Gastroenterology, 2020.

DOI för Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission Ladda ner fulltext (pdf) av Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission

Open access
Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome

Lase, Ieva; Strele, Ieva; Grönberg, Malin; Kozlovacki, Gordana et al.

Ingår i Hormones, s. 351-360, 2020.

DOI för Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome Ladda ner fulltext (pdf) av Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome

Open access
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms

Baudin, Eric; Hayes, Aimee R.; Scoazec, Jean-Yves; Filosso, Pier Luigi et al.

Ingår i Neuroendocrinology, s. 7-17, 2019.

DOI för Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms

Capdevila, Jaume; Bodei, Lisa; Davies, Philippa; Gorbounova, Vera et al.

Ingår i Neuroendocrinology, s. 18-25, 2019.

DOI för Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Carlsen, Esben Andreas; Fazio, Nicola; Granberg, Dan; Grozinsky-Glasberg, Simona et al.

Ingår i Endocrine-Related Cancer, s. 227-239, 2019.

DOI för Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure

Georgantzi, Kleopatra; Sköldenberg, Erik; Tiensuu Janson, Eva; Jakobson, Åke et al.

Ingår i Journal of Pediatric Surgery, s. 1253-1256, 2019.

DOI för Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure
Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Georgantzi, Kleopatra; Tsolakis, Apostolos V.; Jakobson, Åke; Christofferson, Rolf et al.

Ingår i Endocrine pathology, s. 173-179, 2019.

DOI för Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma Ladda ner fulltext (pdf) av Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Open access
Bronchial carcinoids

Granberg, Dan

Ingår i INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2019.

DOI för Bronchial carcinoids Ladda ner fulltext (pdf) av Bronchial carcinoids

Open access
Unmet Needs in Functional and Nonfunctional pancreatic neuroendocrine neoplasms

Jensen, Robert T.; Bodei, Lisa; Capdevila, J.; Couvelard, Anne et al.

Ingår i Neuroendocrinology, s. 26-36, 2019.

DOI för Unmet Needs in Functional and Nonfunctional pancreatic neuroendocrine neoplasms
Colorectal Neuroendocrine Neoplasms - areas of unmet need

Ramage, John K; Valle, Juan; Nieveen van Dijkum, Els J M; Sundin, Anders et al.

Ingår i Neuroendocrinology, s. 45-53, 2019.

DOI för Colorectal Neuroendocrine Neoplasms - areas of unmet need
Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Sorbye, Halfdan; Baudin, Eric; Borbath, Ivan; Caplin, Martyn et al.

Ingår i Neuroendocrinology, s. 54-62, 2019.

DOI för Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)
Unmet Needs in Appendiceal Neuroendocrine Neoplasms

Toumpanakis, Christos; Fazio, Nicola; Tiensuu Janson, Eva; Hörsch, Dieter et al.

Ingår i Neuroendocrinology, s. 37-44, 2019.

DOI för Unmet Needs in Appendiceal Neuroendocrine Neoplasms
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.

Vyakaranam, Achyut Ram; Crona, Joakim; Norlén, Olov; Granberg, Dan et al.

Ingår i Cancers, 2019.

DOI för Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE. Ladda ner fulltext (pdf) av Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.

Open access
Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Ali, Abir A.; Grönberg, Malin; Hjortland, G. O.; Grønbæk, H. et al.

Ingår i Neuroendocrinology, s. 184-184, 2018.

DOI för Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Ali, Abir Salwa; Grönberg, Malin; Langer, Seppo W.; Ladekarl, Morten et al.

Ingår i Medical Oncology, 2018.

DOI för Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3) Ladda ner fulltext (pdf) av Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Open access
RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective

Crona, Joakim; Backman, Samuel; Welin, Staffan; Taieb, David et al.

Ingår i Cancers, 2018.

DOI för RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective Ladda ner fulltext (pdf) av RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective

Open access
A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors

Dam, G.; Grønbæk, H.; Sørbye, H.; Thiis-Evensen, E. et al.

Ingår i Neuroendocrinology, s. 152-152, 2018.

DOI för A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors
Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival.

Daskalakis, Kosmas; Karakatsanis, Andreas; Hessman, Ola; Stuart, Heather C. et al.

Ingår i JAMA Oncology, s. 183-189, 2018.

DOI för Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival.
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Two Phase 3 Studies in Carcinoid Syndrome

Dillon, J.; Kulke, M.; Warner, R.; Bergsland, E. et al.

Ingår i Neuroendocrinology, s. 224-224, 2018.

DOI för Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Two Phase 3 Studies in Carcinoid Syndrome
Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study

Dillon, Joseph S.; Kulke, Matthew H.; Pavel, Marianne; Horsch, Dieter et al.

Ingår i Pancreas, s. 337-338, 2018.

DOI för Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Garske, Ulrike; Sandström, Mattias; Fröss-Baron, Katarzyna; Lundin, Lars et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 970-988, 2018.

DOI för Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity Ladda ner fulltext (pdf) av Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Open access
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.

Georgantzi, Kleopatra; Sköldenberg, Erik; Stridsberg, Mats; Kogner, Per et al.

Ingår i Pediatric Hematology & Oncology, s. 156-165, 2018.

DOI för Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors. Ladda ner fulltext (pdf) av Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.

Open access
Ghrelin expression is associated with a favorable outcome in male breast cancer

Grönberg, Malin; Nilsson, Cecilia; Markholm, Ida; Hedenfalk, Ingrid et al.

Ingår i Scientific Reports, 2018.

DOI för Ghrelin expression is associated with a favorable outcome in male breast cancer Ladda ner fulltext (pdf) av Ghrelin expression is associated with a favorable outcome in male breast cancer

Open access
Plasma Protein Kallikrein-14 Strongly Predicts Pronounced Chromogranin A (CgA) Response in Small Intestinal Neuroendocrine Tumor (NET) Patients after Somatostatin Analog (SSA) Treatment: The Nordic EXPLAIN Biomarker Study

Kjellman, M.; Knigge, U.; Welin, Staffan; Grønbæk, H. et al.

Ingår i Neuroendocrinology, s. 155-155, 2018.

DOI för Plasma Protein Kallikrein-14 Strongly Predicts Pronounced Chromogranin A (CgA) Response in Small Intestinal Neuroendocrine Tumor (NET) Patients after Somatostatin Analog (SSA) Treatment: The Nordic EXPLAIN Biomarker Study
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors

Krauss, Tobias; Ferrara, Alfonso Massimiliano; Links, Thera P.; Wellner, Ulrich et al.

Ingår i Endocrine-Related Cancer, s. 783-793, 2018.

DOI för Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors
Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study

Lesén, Eva; Björstad, Ase; Björholt, Ingela; Marlow, Tom et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 1509-1518, 2018.

DOI för Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study Ladda ner fulltext (pdf) av Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study

Open access

Senast uppdaterad: 2022-06-10

Skriv ut